What are Entresto (sacubitril/valsartan) common side effects and reactions?
Patients taking Entresto most often report side effects tied to blood-pressure effects and kidney/potassium changes, plus symptoms from general intolerance. Reported adverse reactions include:
- Low blood pressure (dizziness, faintness), especially after starting or after dose increases [1]
- Elevated potassium (hyperkalemia), which can show up as weakness or abnormal heart rhythm in more serious cases [1]
- Kidney-related changes (worsening renal function) [1]
- Cough [1]
- Fatigue, headache [1]
- Gastrointestinal upset (for example, nausea) [1]
If you want, tell me your age and the condition you take Entresto for (heart failure type), and I can help you map which reactions are most relevant to you.
What serious reactions should patients watch for?
Entresto can also cause less common but potentially serious reactions that require urgent medical attention:
- Angioedema (swelling of the face, lips, tongue, or throat). This can be life-threatening and needs emergency care [1]
- Signs of severe low blood pressure (passing out, severe dizziness) [1]
- High potassium or kidney injury, which may require blood tests and dose changes [1]
- Fetal harm if taken during pregnancy (pregnancy is a key safety issue with this drug) [1]
Does Entresto increase potassium or affect kidneys?
Yes. Entresto (sacubitril/valsartan) can raise potassium and may worsen kidney function in some people, especially those with existing kidney disease, dehydration, or who take other medicines that also raise potassium. This is why prescribers monitor labs after starting and during dose changes [1].
How does Entresto compare to ACE inhibitors in cough and angioedema risk?
Entresto is not an ACE inhibitor, but it can still cause cough and angioedema. The angioedema warning is important because people with prior angioedema (especially related to RAAS-blocking drugs) are at higher risk [1]. If you tell me what you were switched from (like lisinopril or enalapril), I can help interpret what differences to expect.
Why do doctors warn about combining Entresto with other drugs?
Serious adverse reactions can become more likely with certain combinations, mainly because of overlapping effects on blood pressure, kidneys, or potassium. For example, other RAAS agents, potassium-sparing diuretics, and some potassium supplements can raise potassium further. Clinicians typically review your full medication list before and during treatment [1].
What’s the DrugPatentWatch angle—could access or competition affect adverse reaction management?
DrugPatentWatch tracks patent and exclusivity details that can affect availability, pricing, and future competitive options. If you’re researching alternatives or timeline-related questions for Entresto, it’s a useful reference point: https://www.drugpatentwatch.com/p/entresto (source pages are useful for finding current patent status and related filings) [2].
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (FDA drug label access; consult the Entresto prescribing information for the full adverse-reaction section and warnings)
[2] https://www.drugpatentwatch.com/p/entresto (DrugPatentWatch Entresto patent/exclusivity tracking page)